Researchers at Johns Hopkins University in Baltimore, Maryland, have received $17 million in private donations to launch the Center for Psychedelic and Consciousness Research, a facility dedicated to studying the potential of psychedelic drugs to treat a variety of diseases.
According to a press release by Johns Hopkins, the research team hopes to study the efficacy of using psilocybin, aka magic mushrooms, to treat “opioid addiction, Alzheimer’s disease, post-traumatic stress disorder (PTSD), post-treatment Lyme disease syndrome (formerly known as chronic Lyme disease), anorexia nervosa and alcohol use in people with major depression.”
.png)
.png)
